Gahan Pandina

Gahan Pandina

Company: Janssen

Job title: Senior Director & Venture Leader


Gahan J. Pandina, PhD, is a Senior Director, Compound Development Team Leader in the Janssen Research and Development, Pharmaceutical Companies of Johnson & Johnson, in Titusville, New Jersey. Dr. Pandina’s work includes leading a team to develop and implement tools and technologies to optimize novel medication development for Autism Spectrum Disorder (ASD). He leads another team focused on developing disease interception approaches for prevention and early intervention in mood disorders. Over the past 18 years at Janssen, Dr. Pandina has served as the clinical leader for several global Phase 2a/2b drug development programs in the psychiatry including schizophrenia & cognition, ADHD, mood, anxiety, and sleep disorders. He has worked on three successful Phase 3 registration programs in schizophrenia and ASD and conducted Phase 2 and 3B/4 studies in schizophrenia, mood, ADHD, and anxiety disorders. He is an Adjunct Clinical Associate Professor of Psychiatry at Rutgers-Robert Wood Johnson Medical School in Piscataway, New Jersey, where he teaches in the psychiatry residency and psychology internship programs.

Dr. Pandina is a licensed clinical psychologist, and a member of several international societies including the American Psychological Association, Association of Clinical Research Professionals, and the International Society for CNS Clinical Trials Methodology. He is the author of numerous publications in both pediatric and adult psychiatry and psychology and has a special interest in clinical research on the efficacy and outcomes of psychiatric and psychological treatments. He serves on the board of a non-profit organization focused on mental health needs.

Dr. Pandina received his Bachelor of Arts degree in psychology from the University of Vermont, and his PhD in Clinical Psychology from Binghamton University in Binghamton, New York, and completed doctoral fellowships in both Neuropsychology and Child and Adolescent Neuropsychology at the Robert Wood Johnson Medical School in Piscataway, New Jersey.


Janssen’s Attrition Mission: A UX Case Study 12:00 pm

Keeping the patient journey paramount to decrease attrition rates Understanding how to keep patients engaged with mHealth technologies Revealing how UX has helped improve patient retention & adherenceRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.